Alzamend Neuro plans a Phase 2 trial of AL001 for PTSD in late 2025, aiming for better lithium delivery, improved safety, and ...

Nonclinical data show AL001 improves brain absorption with lower blood levels than lithium carbonate ... individuals and patients with Alzheimer's, bipolar disorder, major depressive disorder ...

The phase II clinical study of AL001 for bipolar disorder is expected ... Current U.S. Food and Drug Administration-approved lithium salts (carbonate and citrate) are limited by a narrow ...

Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in Bipolar Disorder subjects ...

Current U.S. Food and Drug Administration-approved lithium salts (carbonate and citrate) are limited by a narrow therapeutic window that requires regular TDM of plasma lithium levels and blood ...

These trials will compare the pharmacokinetics of Alzamend’s AL001 with traditional lithium carbonate for neurological ... like Alzheimer’s and bipolar disorder. Alzamend’s collaboration ...

Findings suggest unknown exposure source, lead author says, as study highlights potential health risks of high environmental lithium Pregnant women and newborns in Beijing carry blood lithium levels ...

Some of these forms, such as lithium carbonate, are used to make the medications that treat bipolar disorder. Lithium belongs to a class of medications called mood-stabilizing agents, which are ...